McKesson [MCK] vs Henry Schein [HSIC] Detailed Stock Comparison

McKesson
NYSE
Loading...

Henry Schein
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: McKesson wins in 11 metrics, Henry Schein wins in 8 metrics, with 0 ties. McKesson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | McKesson | Henry Schein | Better |
---|---|---|---|
P/E Ratio (TTM) | 27.10 | 21.79 | Henry Schein |
Price-to-Book Ratio | -100.73 | 2.40 | McKesson |
Debt-to-Equity Ratio | -11.52 | 68.55 | McKesson |
PEG Ratio | -2.51 | -1.77 | McKesson |
EV/EBITDA | 16.56 | 12.42 | Henry Schein |
Profit Margin (TTM) | 0.84% | 3.05% | Henry Schein |
Operating Margin (TTM) | 1.29% | 5.40% | Henry Schein |
EBITDA Margin (TTM) | 1.29% | 5.40% | Henry Schein |
Return on Equity | -194.51% | 8.12% | Henry Schein |
Return on Assets (TTM) | 4.18% | 4.54% | Henry Schein |
Free Cash Flow (TTM) | $5.23B | $661.00M | McKesson |
Dividend Yield | 0.29% | N/A | N/A |
1-Year Return | 27.86% | -3.69% | McKesson |
Price-to-Sales Ratio (TTM) | 0.22 | 0.64 | McKesson |
Enterprise Value | $92.83B | $12.89B | McKesson |
EV/Revenue Ratio | 0.25 | 1.01 | McKesson |
Gross Profit Margin (TTM) | 3.35% | 31.36% | Henry Schein |
Revenue per Share (TTM) | $2,993 | $103 | McKesson |
Earnings per Share (Diluted) | $24.98 | $3.11 | McKesson |
Beta (Stock Volatility) | 0.50 | 0.82 | McKesson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
McKesson vs Henry Schein Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
McKesson | -2.41% | 4.78% | -0.73% | -1.77% | 18.12% | 24.69% |
Henry Schein | 2.02% | 0.44% | -1.25% | -5.37% | -11.69% | -0.50% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
McKesson | 27.86% | 97.88% | 358.83% | 251.59% | 1,069.65% | 1,447.57% |
Henry Schein | -3.69% | -7.06% | 2.66% | 24.77% | 227.30% | 329.80% |
Performance & Financial Health Analysis: McKesson vs Henry Schein
Metric | MCK | HSIC |
---|---|---|
Market Information | ||
Market Cap | $84.20B | $8.22B |
Market Cap Category | Large cap | Mid cap |
10 Day Avg. Volume | 1,019,480 | 2,292,793 |
90 Day Avg. Volume | 756,397 | 1,958,574 |
Last Close | $689.00 | $69.59 |
52 Week Range | $464.42 - $737.89 | $60.56 - $82.49 |
% from 52W High | -6.63% | -15.64% |
All-Time High | $738.40 (Jul 08, 2025) | $92.68 (Apr 11, 2022) |
% from All-Time High | -6.69% | -24.91% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.23% | 0.03% |
Quarterly Earnings Growth | -0.14% | -0.17% |
Financial Health | ||
Profit Margin (TTM) | 0.01% | 0.03% |
Operating Margin (TTM) | 0.01% | 0.05% |
Return on Equity (TTM) | -1.95% | 0.08% |
Debt to Equity (MRQ) | -11.52 | 68.55 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $-15.74 | $28.26 |
Cash per Share (MRQ) | $19.44 | $1.20 |
Operating Cash Flow (TTM) | $6.55B | $512.00M |
Levered Free Cash Flow (TTM) | $5.29B | $358.25M |
Dividends | ||
Last 12-Month Dividend Yield | 0.29% | N/A |
Last 12-Month Dividend | $2.13 | N/A |
Valuation & Enterprise Metrics Analysis: McKesson vs Henry Schein
Metric | MCK | HSIC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 27.10 | 21.79 |
Forward P/E | 18.39 | 13.03 |
PEG Ratio | -2.51 | -1.77 |
Price to Sales (TTM) | 0.22 | 0.64 |
Price to Book (MRQ) | -100.73 | 2.40 |
Market Capitalization | ||
Market Capitalization | $84.20B | $8.22B |
Enterprise Value | $92.83B | $12.89B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 0.25 | 1.01 |
Enterprise to EBITDA | 16.56 | 12.42 |
Risk & Other Metrics | ||
Beta | 0.50 | 0.82 |
Book Value per Share (MRQ) | $-15.74 | $28.26 |
Financial Statements Comparison: McKesson vs Henry Schein
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | MCK | HSIC |
---|---|---|
Revenue/Sales | $90.82B | $3.17B |
Cost of Goods Sold | $87.18B | $2.17B |
Gross Profit | $3.64B | $1.00B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | $1.66B | $200.00M |
EBITDA | $1.72B | $278.00M |
Pre-Tax Income | $1.52B | $145.00M |
Income Tax | $209.00M | $35.00M |
Net Income (Profit) | $1.31B | $113.00M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | MCK | HSIC |
---|---|---|
Cash & Equivalents | $5.69B | $127.00M |
Total Current Assets | $55.40B | $4.04B |
Total Current Liabilities | $61.60B | $2.92B |
Long-Term Debt | $5.94B | $2.22B |
Total Shareholders Equity | $-1.69B | $4.72B |
Retained Earnings | $17.92B | $3.63B |
Property, Plant & Equipment | $1.78B | $850.00M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | MCK | HSIC |
---|---|---|
Operating Cash Flow | $2.18B | $147.00M |
Capital Expenditures | $-169.00M | $-31.00M |
Free Cash Flow | $7.47B | $-6.00M |
Debt Repayment | $-6.13B | $-15.00M |
Common Stock Repurchase | $-300.00M | $-161.00M |
Short Interest & Institutional Ownership Analysis
Metric | MCK | HSIC |
---|---|---|
Shares Short | 1.88M | 7.78M |
Short Ratio | 3.10 | 4.75 |
Short % of Float | 0.02% | 0.07% |
Average Daily Volume (10 Day) | 1,019,480 | 2,292,793 |
Average Daily Volume (90 Day) | 756,397 | 1,958,574 |
Shares Outstanding | 125.00M | 124.16M |
Float Shares | 124.19M | 103.82M |
% Held by Insiders | 0.00% | 0.01% |
% Held by Institutions | 0.91% | 1.14% |
Dividend Analysis & Yield Comparison: McKesson vs Henry Schein
Metric | MCK | HSIC |
---|---|---|
Last 12-Month Dividend | $2.13 | N/A |
Last 12-Month Dividend Yield | 0.29% | N/A |
3-Year Avg Annual Dividend | $2.05 | N/A |
3-Year Avg Dividend Yield | 0.13% | N/A |
3-Year Total Dividends | $6.15 | N/A |
Ex-Dividend Date | Mar 03, 2025 | N/A |